Skip to main content
. Author manuscript; available in PMC: 2011 Oct 7.
Published in final edited form as: Cancer Res. 2010 Feb 2;70(4):1459–1468. doi: 10.1158/0008-5472.CAN-09-3798

Table 1.

Haplotypes in CLOCK gene and breast cancer risk

ER/PR + ER/PR −

Common or
Variant Allele*
Frequency
%
Controls
N
Cases
N
OR
(95% CI)
Cases
N
OR
(95% CI)
Cases
N
OR(95% CI)
CVCCVCCCC 33.48% 321 286 0.95 (0.78-1.16) 54 0.94 (0.66-1.36) 44 0.68 (0.46-0.99)
VCCCCVVCV 23.65% 216 215 1.18 (0.95-1.48) 38 1.13 (0.75-1.70) 48 1.54 (1.04-2.27)
CCVVCCCVC 18.47% 191 143 0.78 (061-1.00) 29 0.79 (0.51-1.24) 31 0.88 (0.57-1.36)
CCVVCVCVC 12.74% 120 110 0.97 (0.73-1.28) 22 1.02 (0.62-1.70) 25 1.17 (0.72-1.91)
CCVCCCCVC 4.27% 40 35 0.98 (0.61-1.57) 5 0.78 (0.29-2.07) 5 0.87 (0.32-2.32)
VVCCCVVCV 3.56% 24 38 1.87 (1.10-3.18) 11 2.25 (1.04-4.87) 6 1.33 (0.52-3.43)
Protective
Allele
36.49% 363 293 0.81 (0.66-0.98) 58 0.82 (0.57-1.17) 61 0.91 (0.63-1.29)
1+ Risk Alleles 42.81% 386 389 1.23 (1.01-1.48) 76 1.27 (0.90-1.79) 85 1.51 (1.07-2.14)
2+ Risk Alleles 28.43% 265 250 1.31 (1.06-1.61) 51 1.32 (0.90-1.92) 57 1.59 (1.10-2.30)
3 Risk Alleles 28.11% 249 260 1.28 (1.04-1.58) 49 1.26 (0.86-1.84) 57 1.60 (1.11-2.32)
*

SNP order: rs7698022, rs6850524, rs11133391, rs11133389, rs13102385, rs11932595, rs1801260, rs3749474, rs1048004

Adjusted for age, race, family history of breast cancer, study site, menopausal status, age at menarche, and parity.